/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced.
/PRNewswire/ Philip J. Clements, MD, MPH, MACR, is being recognized by Continental Who s Who as a Top Distinguished Doctor in the field of Rheumatology and.